Tullis Growth Fund

Type

Venture Capital

Status

Active

Location

North Palm Beach, United States

Total investments

41

Average round size

14M

Portfolio companies

21

Rounds per year

1.08

Lead investments

8

Follow on index

0.49

Exits

16

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareHealth DiagnosticsGeneticsManufacturingMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

Tullis Health Investors is the famous VC, which was founded in 1986. The main office of represented VC is situated in the Stamford. The fund was located in North America if to be more exact in United States.

The overall number of key employees were 2.

The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Tullis Health Investors works on 3 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2011. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2009.

Among the various public portfolio startups of the fund, we may underline Synageva BioPharma, CareSync, Surefire Medical For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Software, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Tullis Health Investors, startups are often financed by Sun Mountain Capital, EPIC Ventures, Cottonwood Technology Fund. The meaningful sponsors for the fund in investment in the same round are Sun Mountain Capital, Cottonwood Technology Fund, EPIC Ventures. In the next rounds fund is usually obtained by Sun Mountain Capital, Cottonwood Technology Fund, EPIC Ventures.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareMedtech
Stage focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 21400000

Analytics

Total investments
41
Lead investments
8
Exits
16
Rounds per year
1.08
Follow on index
0.49
Investments by industry
  • Health Care (35)
  • Biotechnology (23)
  • Medical (15)
  • Therapeutics (12)
  • Health Diagnostics (12)
  • Show 19 more
Investments by region
  • United States (41)
Peak activity year
2009
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
432M
Group Appearance index
0.88
Avg. company exit year
11
Avg. multiplicator
7.52
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Boundless Bio 28 Apr 2021 Biotechnology, Health Care, Life Science, Therapeutics Early Stage Venture 105M United States, California, San Diego
CareSync 07 Oct 2015 Software, Information Technology, Health Care, mHealth Early Stage Venture 18M United States, Florida, Tampa
Sicuro Food 01 Jan 2020 Food and Beverage, AgTech, Agriculture Seed 100K Lazio, Roma, Italy
Valeo Medical 16 Nov 2004 Biotechnology, Health Care, Life Science Early Stage Venture 6M United States, Massachusetts

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.